Two Sigma Advisers »

Acrivon Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $247k 137k 1.81
2025-06-30 $39k 33k 1.19

More positions owned by Two Sigma Advisers

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Meta Platforms Cl A (META)
Bank of America Corporation (BAC)
Mastercard Incorporated Cl A (MA)
Costco Wholesale Corporation (COST)
Lockheed Martin Corporation (LMT)
Intuitive Surgical Com New (ISRG)
Adobe Systems Incorporated (ADBE)
Charles Schwab Corporation (SCHW)

View all positions for Two Sigma Advisers

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Citadel Advisors
Wellington Management Company
UBS Group
Vanguard Group
Renaissance Technologies
Acorn Capital Advisors
BlackRock
Two Sigma Investments
Jane Street
Geode Capital Management
Millennium Management
Marshall Wace
Two Sigma Advisers

View all funds holding Acrivon Therapeutics